Atarax and Nexavar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atarax (hydroxyzine hydrochloride) and Nexavar (sorafenib tosylate). Common drug interactions include acute respiratory failure among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Atarax and Nexavar. It is created by eHealthMe based on reports of 70 people who take the same drugs from the FDA, and is updated regularly.

What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 23,553 Atarax users. Check the latest studies of Atarax.

What is Nexavar?

Nexavar has active ingredients of sorafenib tosylate. It is often used in hepatocellular carcinoma. eHealthMe is studying from 23,250 Nexavar users. Check the latest studies of Nexavar.



On Jul, 29, 2026

70 people who take Atarax and Nexavar together, and have interactions are studied.

Atarax and Nexavar drug interactions.

What are the common drug interactions of Atarax and Nexavar, by gender? *:

female:

  1. Acute respiratory failure
  2. Asthenia (weakness)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Blood pressure increased
  5. Body temperature increased
  6. Catheter site pain
  7. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  8. Chills (felling of cold)
  9. Dry skin
  10. Ear pain

male:

  1. Diarrhoea
  2. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  3. Decreased appetite
  4. Hypertension (high blood pressure)
  5. Haemoglobin decreased
  6. Pleural effusion (water on the lungs)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. White blood cell count decreased
  10. Cough

What are the common drug interactions of Atarax and Nexavar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Asthenia (weakness)
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Blood pressure increased
  4. Body temperature increased
  5. Catheter site pain
  6. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  7. Chills (felling of cold)
  8. Diarrhoea
  9. Dry skin
  10. Ear pain

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  2. Blood amylase increased
  3. Constipation
  4. Amylase increased
  5. Platelet count decreased
  6. Haematuria (presence of blood in urine)
  7. Pleural effusion (water on the lungs)
  8. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)

60+:

  1. Diarrhoea
  2. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
  3. Pyrexia (fever)
  4. White blood cell count decreased
  5. Cough
  6. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  7. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  8. Dyspepsia (indigestion)
  9. Hepatic neoplasm malignant (liver cancer)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

What are the existing conditions these people have? *

  1. Hepatic Neoplasm Malignant (liver cancer): 26 people, 37.14%
  2. Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 15 people, 21.43%
  3. Renal Cell Carcinoma (a kidney cancer): 14 people, 20.00%
  4. Pain: 9 people, 12.86%
  5. Insomnia (sleeplessness): 9 people, 12.86%
  6. Constipation: 9 people, 12.86%
  7. Itching: 7 people, 10.00%
  8. High Blood Pressure: 5 people, 7.14%
  9. Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 4 people, 5.71%
  10. Nausea (feeling of having an urge to vomit): 4 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Atarax and Nexavar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atarax and Nexavar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atarax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexavar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atarax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexavar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and sorafenib tosylate (the active ingredients of Atarax and Nexavar, respectively), and Atarax and Nexavar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: